# Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies

> **NCT04878822** · — · UNKNOWN · sponsor: **Ospedale di Circolo - Fondazione Macchi** · enrollment: 300 (estimated)

## Conditions studied

- Immunogenicity
- Hematological Malignancies
- Covid-19
- Vaccine Response Impaired

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04878822
- **Lead sponsor:** Ospedale di Circolo - Fondazione Macchi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-13
- **Primary completion:** 2021-07-31
- **Final completion:** 2023-04-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04878822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04878822, "Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04878822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*